Onconic Therapeutics
Latest round
- Series B
Last raised
- Dec 2022
Total raised
- $44M
Investors
- 11
About Onconic Therapeutics
, a subsidiary of Jeil Pharmaceutical, operates as a drug development company. In March 2021, Onconic Therapeutics Inc. In December 2022, Onconic Therapeutics Inc. As of 2022, the company’s CEO is John Kim. Onconic conducts various research and development activities in order to develop drugs for cancer and gastrointestinal diseases. The product line of the company includes OCN-201, which is an anti-cancer drug, and Zastaprazan (OCN-101), which is a potassium-competitive acid blocker (P-CAB) for gastric acid-related diseases.
Who invested in Onconic Therapeutics
11 investors across 2 rounds
See all investors in Onconic Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Onconic Therapeutics
Who invested in Onconic Therapeutics?
Onconic Therapeutics has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Onconic Therapeutics raised?
Onconic Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Onconic Therapeutics last raise money?
Onconic Therapeutics's most recent round on record is a Series B, in Dec 2022.
What does Onconic Therapeutics do?
, a subsidiary of Jeil Pharmaceutical, operates as a drug development company.
Where is Onconic Therapeutics headquartered?
Onconic Therapeutics is headquartered in Seoul, South Korea.
Which VCs invest in companies like Onconic Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Onconic Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Onconic Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.